European Archives - Page 195 of 1369 - European Medical Journal

Carbon Build-up in Lungs Linked to COPD Severity

Macrophages in COPD lungs show elevated carbon loads, larger cell size, and enhanced inflammation, highlighting a potential driver of disease progression.

Monitoring Nocturnal Scratching for Atopic Dermatitis Care with Wearables

Wearable and touchless technologies reliably measure nocturnal scratching in atopic dermatitis, supporting at-home monitoring for better care.

JAK Inhibition Protects Against Immunotherapy-Driven Diabetes

In a new study, researchers identified a specific immune cell type, CD4+ T follicular helper (Tfh) cells producing IL-21 and IFN-γ, as a key driver of ICI-T1DM.

Onc Now: Episode 21: Redesigning Cancer Care Through Precision Medicine

In this episode Jonathan is joined by Jean Abraham, to delve into the future of integrated cancer medicine, the evolving role of clinical trials, and how precision oncology is redefining outcomes for patients with breast cancer across the UK.

HLTH Europe 2025 Interview: Henry Stoneley

The theme for HLTH Europe 2025 was intentionally chosen. Growth can be exhilarating; it can feel like momentum…

Postbiotics Show Promise in Slowing Liver Fibrosis

While the primary outcome, a ≥10% reduction in α-SMA, was reached in 29% of ReFerm® recipients versus 14% in the control group, the difference was not statistically significant.

Artificial Sweetener Erythritol Linked to Brain Vascular Cell Dysfunction

Erythritol at common dietary levels impairs brain endothelial cell function, raising new concerns for cerebrovascular health.

Smoking and Obesity Lower TNFi Success in axSpA

A European study of nearly 15,000 patients finds that smoking and high BMI lower the odds of response to TNF inhibitors in axial spondyloarthritis.

WHO Backs Twice-Yearly Lenacapavir Injection for HIV Prevention

WHO has endorsed injectable lenacapavir as a twice-yearly HIV prevention tool, offering new hope for communities facing high infection risks and adherence barriers.

Long-Term Psoriasis Drug Use Shows Low Cancer Risk

This post hoc analysis included data from 25 randomised clinical trials, assessing over five years of IXE exposure in patients with psoriasis.